We demonstrate here that the release of mature cytochrome c from mitochondria is a cellular response to the depletion of glutathione, the main intracellular antioxidant, independently from the destiny of the cells, i.e., apoptosis or survival. On the one hand, cytosolic cytochrome c was detected in cells where the inhibition of glutathione synthesis led to glutathione depletion without impairing viability or in tight concomitance with glutathione depletion prior to puromycin-induced apoptosis. Removal of the apoptogenic agent prior to apoptosis, but after glutathione extrusion and cytochrome c release, led to recovery of preapoptotic cells, which resume healthy features, i.e., restoration of normal glutathione levels and disappearance of cytosolic cytochrome c. On the other hand, in an example of apoptosis occurring without glutathione depletion, no translocation of cytochrome c from mitochondria to cytosol was detected. Unlike the other instances of apoptosis, in this case caspase 3 was not activated, thus suggesting the following oxidant-related apoptotic pathway: glutathione depletion, cytochrome c release, and caspase 3 activation. These results show that cytochrome c release is not a terminal event leading cells to apoptosis, but rather is the consequence of a redox disequilibrium that, under some circumstances, may be associated with apoptosis.-Ghibelli, L., Coppola, S., Fanelli, C., Rotilio, G., Civitareale, P., Scovassi, A. I., Ciriolo, M. R. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis.
Cytochrome C is a nuclear-encoded component of the mitochondrial respiratory chain that is imported as an apoenzyme into mitochondria, where it is converted to the mature form by the addition of a heme group. It catalyzes electron transfer between complexes III and IV of the respiratory chain, moving within the planar surface of the inner mitochondrial membrane. Recently, other functions have been postulated for mature cytochrome c upon relocalization to the cytosol, thus implying a specific mechanism of export. It could act as a direct redox agent for NADH oxidation (1) in healthy (stressed?) cells whereas in apoptosing cells, it may activate the cascade of caspases (2) , a set of cysteine proteases that are responsible for the ultimate degradation of key structural and regulatory proteins during apoptosis (3) . Cytosolic cytochrome c catalyzes the proteolytic activation of caspase 9, which in turn activates caspase 3 (4), considered to be the key regulator of the proteolytic events that lead to the morphofunctional changes occurring in the execution phase of apoptosis.
A crucial role for cytochrome c release in apoptosis was stressed by some recent studies demonstrating that cytochrome c directly microinjected in the cytoplasms of a variety of cell types is capable of triggering apoptosis on its own (5), while APAF-1 is needed as a cofactor in cell free extracts (2) . In contrast, examples of apoptosis without cytochrome c release (6) indicate that this event may not be necessary, at least in some apoptotic pathways. Further investigations are required in order to elucidate the role of cytochrome c in apoptosis.
Another open matter is the mechanism that triggers cytochrome c relocalization to the cytosol, which requires the passage through the outer mitochondrial membrane. A novel mechanism of protein export from mitochondria that is dependent on Bax (7-9) and/or Bid (10), two members of the Bcl-2 family of proteins that regulate apoptosis, has recently been postulated. It involves the translocation of Bid or Bax from the cytosol to mitochondria (10, 11) , where they may possibly form a pore, as shown for the related protein Bcl-X L (12); Bax translocation requires homodimerization (13) , achieved by disulfide bond formation (14) . As an alternative model, it has been proposed that cytochrome c may be released via the opening of the mitochondrial permeability transition pore (PTP) (15, 16) , possibly as a result of mitochondrial swelling-induced outer membrane damage (17) ; PTP opening is a complex phenomenon, controlled by the mitochondrial redox potential (18) .
Glutathione is the key regulator of intracellular redox status; it performs an antioxidant cell-protective action, cycling between its reduced (GSH) and oxidized (GSSG) forms. We (19) and others (20) have demonstrated that upon apoptogenic stimuli that do not directly elicit an oxidative stress, glutathione is extruded from the apoptosing cells in its reduced form. More recently, we reported that prevention of GSH extrusion prevents apoptosis, showing that GSH extrusion is necessary for the downstream events of apoptosis, probably via the alteration of the intracellular redox signaling (21) .
Redox alterations are involved in both the proposed models of cytochrome c export by facilitating PTP opening (15) , on the one hand, and on the other by promoting disulfide bonds formation leading to Bax homodimerization (14) . This led us to hypothesize that GSH depletion and the consequent redox disequilibrium might directly cause cytochrome c release; this might possibly explain how GSH extrusion triggers apoptosis. We could demonstrate that the release of mature cytochrome c from mitochondria is indeed a cellular response to the depletion of glutathione, independently from the destiny of the cells (i.e., apoptosis or survival). This implies that the extremely common redox imbalance occurring during apoptosis may be the trigger for cytochrome c export.
MATERIALS AND METHODS

Cell culture and treatments
U937 and HepG2 cells were cultured as described (21) . All the experiments were performed in complete medium on log phase cells at a cell density of 7 ϫ 10 5 cells/ml (U937) and 2 ϫ 10 6 /25 cm 2 flasks (HepG2). Apoptosis was induced with 10 g/ml purumycin (PMC) or 3-5 mM dithiothreitol (DTT) for the time indicated. For detection of apoptosis, cells were stained with the DNA-specific, cell-permeable dye Hoechst 33342; apoptotic cells were recognized according to their nuclear morphology (different stages of nuclear fragmentation) (22, 23) . Apoptosis was quantitated as described in ref 21 ; briefly, the fraction of U937 or HepG2 cells with fragmented nuclei among the total cell population is calculated in the Hoechst 33342 stained cells, counting at least 300 cells in at least 10 random selected fields.
Glutathione depletion was achieved by inhibiting glutathione neosynthesis with 1 mM buthionine sulfoximine (BSO) for the indicated time.
Glutathione determination
U937 and HepG2 cells were harvested, lysed, and proteins were precipitated from lysates as described previously (21) .
The clear supernatant was used for GSH and GSSG determination by high-performance liquid chromatography (21) . Basal values of intracellular GSH content were 50.64 Ϯ 13.67 (HepG2) and 46.54 Ϯ 13.98 (U937) nmol of GSH/mg of protein. The values of GSH loss are calculated as the percent of reduction of GSH in treated samples with respect to control values.
Caspase 3 activation
For sample preparations, 10 7 cells were washed and collected by centrifugation (preceded by trypsinization for HepG2) at 200 ϫ g for 5 min. The cell pellet was resuspended in 100 l lysis buffer (40 mM sucrose, 50 mM NaCl, 2 mM MgCl 2 , 5 mM EGTA, 10 mM HEPES, pHϭ7) and subjected to three cycles of freeze and thaw. The supernatants recovered after 30 min 15,000 ϫ g spin were stored at Ϫ70°C until analysis. Assay: 10 l of extract was added to caspase assay buffer (10% sucrose, 0.1% Nonidet P40, 10 mM DTT, 100 mM HEPES, pH 7.25) in a total volume of 1 ml in the presence of 40 M florogenic substrate specific for caspase 3 z-DEVDafc. The increase in fluorescence due to substrate cleavage was monitored in a fluorometer tuned at 400 nm (excitation) and 505 nm (emission). The values are expressed as arbitrary units obtained by monitoring the increase in fluorescence of treated samples with respect to controls.
The specificity of caspase 3 activation was always controlled with the immunoblotting assay (see below), which allows detection of the disappearance of the 32 kDa band as a sign of proteolytic activation of caspase 3. This assay always confirmed the results obtained with the fluorometric assay.
Preparations of cytosolic extracts and immunoblotting
Cells were washed and collected by centrifugation (preceded by trypsinization for HepG2) at 200 ϫ g for 5 min and at 4°C. The cell pellet was resuspended in 600 l of extraction buffer containing 220 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM DTT, and protease inhibitors. After 30 min incubation on ice, cells were homogenized with an Eppendorf pestle. Cell homogenates were spun at 14,000 ϫ g for 15 min; supernatants were removed and stored at Ϫ80°C until analysis by gel electrophoresis. Fifty micrograms of cytosolic protein extracts was loaded onto each lane of a 12% sodium dodecyl sulfate (SDS) -polyacrylamide gel, separated, and blotted to nitrocellulose membrane (Bio-Rad). Anti-cytochrome c mouse monoclonal antibody (PharMingen) or anti-caspase 3 (CPP32) goat polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.) was used as primary antibodies. The specific protein complexes formed upon appropriate secondary antibody treatment were identified using the 'SuperSignal' substrate chemiluminescence reagent (Pierce, Rockford, Ill.). The quantitation was obtained with densitometric scanning with a LKB ultrascan XL laser densitometer coupled with a LKB 2400 GelScan XL software package; the values are referred to the total cellular cytochrome c.
PARP proteolysis
Western blot analysis was carried out essentially as described in ref 24 . Briefly, cells were washed twice with ice-cold PBS and resuspended at the concentration of 5 ϫ 10 6 /ml in a buffer containing 62.5 mM Tris-HCl pH 6.8, 4 M urea, 10% glycerol, 2% SDS, 5% ␤-mercaptoethanol, and 0.003% bromophenol blue, as described in ref 25 . Cells were then disrupted by sonication on ice, twice for 30 s (60 W). Equal volumes (corresponding to 30 l) of each sample were incubated for 15 min at 65°C before loading on SDS-polyacrylamide gel. Samples were electrophoresed in a 7.5% SDS-PAGE minigel and transferred onto a nitrocellulose filter (Bio-Rad, Hercules, Calif.) for 3 h at 4°C under a constant voltage of 120 V (26). The membrane was saturated overnight with PTN (PBS containing 0.1% Tween-20 and 10% newborn calf serum) and then incubated for 3 h with the monoclonal antibody C-2-10 kindly provided by Dr. G. Poirier (diluted 1:10,000 in PTN), which recognizes an epitope located between the zinc finger region and the automodification domain, at the carboxyl end of the DNA-binding domain of poly(ADPribosyl)polymerase (PARP) (26) . After washings with PBS containing 0.2% Tween 20, the membrane was incubated for 2 h with anti-mouse IgG conjugated with peroxidase. Visualization of immunoreactive peptides was achieved by ECL system (NEN Dupont, Boston, Mass.).
RESULTS
Apoptotic cytochrome c release occurs in concomitance with GSH extrusion and before commitment to death
In HepG2 cells induced to apoptosis by puromycin (PMC), GSH extrusion occurs very early, well before any sign of nuclear alterations (21) . In Fig.  1 we show that cytochrome c release and GSH loss occur in tight concomitance, both preceding caspase 3 activation and nuclear apoptosis. Notably, glutathione is depleted by 38% at 4 h of treatment (Fig. 1A) and cytochrome c is released into the cytosol (Fig. 1A, B) , but no caspase 3 activation or apoptosis is detectable (Fig. 1A) ; thus, despite having released cytochrome c, these cells are not dead. As a matter of fact, they are not even committed to death: upon removal of PMC, they escape apoptosis. After 14 h of additional culture in PMC-free medium, they were still viable: GSH levels were restored to control values and any trace of cytochrome c had disappeared from the cytosol (Fig. 1C) . This set of experiments shows that cytochrome c is released by preapoptotic cells concomitant with GSH extrusion and that both events occur before the irreversible commitment to death; this urged us to investigate a possible link between glutathione extrusion and cytochrome c release.
BSO-induced depletion of GSH causes cytochrome c release without affecting cell viability
To investigate the latter assumption, we asked whether cytochrome c moves to cytosol when GSH is depleted without apoptosis. We took advantage of the possibility of uncoupling glutathione depletion and apoptosis. Indeed, HepG2 and U937 cells treated with 1 mM BSO, a compound that inhibits glutathione neosynthesis, had their glutathione content decreased without undergoing apoptosis (19) . We found that these glutathione-depleted cells do release a substantial amount of cytochrome c in their cytosolic fraction ( Fig. 2A, B) already in the first few hours of treatment. This is not accompanied by caspase 3 activation or apoptosis ( Fig. 2A) . In fact, no loss of viability occurs even for longer incubation times, and GSH-depleted cells remained viable and capable of replicating for several days in the continuous presence of BSO (Fig. 2C) . These results show that cytochrome c is released from mitochondria as a consequence of the diminution of intracellular glutathione content and that these events per se are not necessarily leading to apoptosis. 
DTT-induced apoptosis occurs without GSH depletion, cytochrome c release or caspase 3 activation
So far we have shown that GSH depletion, a common apoptotic event, is sufficient to cause cytochrome c translocation to the cytosol. Is GSH depletion or the consequent oxidative status also necessary for cytochrome c release? To answer to this question, we attempted to uncouple apoptosis from GSH extrusion.
We found that high doses (1-5 mM) of the reducing agent DTT induce apoptosis on U937 and HepG2 cells. This apoptosis consequent to a 'reducing stress' is characterized by regular apoptotic morphology (i.e., nuclear vesiculation), but it occurs without GSH loss (Fig. 3A) . We wondered whether cytochrome c would be released in cells induced to apoptosis by DTT, as generally occurs in apoptotic U937, or whether in this case the lack of an oxidative environment would prevent cytochrome c export. Figure 3A , B shows that no cytosolic cytochrome c is detectable. This suggests that GSH extrusion or the redox imbalance consequent to it is necessary for cytochrome c translocation in apoptosis.
Caspase 3 is not activated in DTT-induced apoptosis even though PARP is cleaved
It is known that caspase 3 is activated as a result of cytochrome c release (4). Thus, we wondered whether caspase 3 is active in U937 induced to apoptosis by DTT despite the absence of cytosolic cytochrome c. As shown in Fig. 3A , in this case caspase 3 is not activated. Apoptosis without caspase 3 activation has recently been described in the epithelial cell line MCF7 (27) . Indeed, MCF7 are able to undergo apoptosis in a canonical way, i.e., the nuclei vesiculate normally and PARP, a known target of caspase 3 action (28) , is regularly cleaved, conceivably by other proteases. Thus, we analyzed PARP status in DTT-induced apoptosis; we also observed a caspase 3-independent PARP cleavage (Fig. 3C) . This means that DTT induces a canonical apoptosis (nuclear vesiculation, caspase activation, etc.) by eliciting a noncanonical pathway that bypasses glutathione extrusion, cytochrome c release, and caspase 3 activation.
DISCUSSION
In this study we demonstrate that a diminution of the intracellular glutathione content causes cytochrome c release from mitochondria. The release of cytochrome c occurs in all instances of glutathione depletion, obtained either by direct inhibition of glutathione neosynthesis (with BSO) or indirectly, by eliciting apoptosis-linked GSH extrusion. Instead, no correlation was found between cytochrome c release and apoptosis, since cytochrome c can also be released in viable cells (when GSH is depleted), whereas cells might undergo apoptosis without releasing cytochrome c (when apoptotic cells maintain regular GSH levels). All this evidence indicates that the rationale for cytochrome c release in apoptosis is the extrusion of GSH, an event that often accompanies apoptotic signaling (19 -21) .
We have recently shown that the forced maintenance of GSH inside cells pushed to apoptosis by PMC or etoposide increases cell survival, implying that GSH depletion is a necessary step in order to trigger apoptosis by affecting some crucial intracellular target via redox disequilibrium (21) . The results presented here indicate that the modality through which GSH depletion triggers the downstream events of apoptosis is indeed by promoting cytochrome c release.
The redox disequilibrium consequent to GSH depletion is likely to be the direct cause for cytochrome c translocation, since the mechanisms proposed to be responsible for cytochrome c release (PTP opening and Bax dimerization/translocation to mitochondria) are controlled by redox alterations. PTP opening is known to be facilitated by an oxidant environment (18) , whereas Bax homodimerization, which occurs via the formation of disulfide bonds (14) , is mostly favored in the absence of GSH.
DTT is a reducing agent that interferes with the formation of protein disulfide bridges. This is also one of the most important functions that GSH exerts in the cytosol, where it contrasts the formation of cystein disulfide bonds. Thus, the inability of cytochrome c to translocate to the cytosol during DTTinduced apoptosis fits with our model, which proposes the requirement of an oxidant environment for cytochrome c release. The finding that upon DTT treatment apoptosis occurs without glutathione depletion, translocation of cytochrome c, or caspase 3 activation indicates that these are three events of the intracellular apoptotic signaling that are tightly linked, and may occur sequentially, delineating a precise apoptotic pathway. Much effort is currently being expended to study the role of cytochrome c release in apoptosis, with still confusing and apparently contradictory results. Indeed, this event has been found to be a trigger for apoptosis (2, 5), while not occurring at all in some systems (6) . Our study might help to solve these contradictions by suggesting that cytochrome c might play a role only in some apoptotic pathways, i.e., those involving redox imbalance.
Reconstruction experiments have shown that cytosolic cytochrome c needs APAF-1 as a cofactor in the proteolytic activation of caspase 9, which in turn activates caspase 3 (4). This may explain why cytosolic cytochrome c per se is not necessarily leading to apoptosis in our experiments. It is possible that in U937 or HepG2 cells depleted of glutathione by BSO, no APAF-1 is free (ready) to cooperate with cytochrome c to initiate the apoptotic cascade; likewise, in HepG2 induced to apoptosis by PMC (Fig.  1) , the early released cytochrome c might have to wait until a cofactor is available.
In conclusion, we show that cytosolic cytochrome c is a transient phenomenon, compatible with cell viability, occurring in instances of redox imbalance. In these situations, the release of cytochrome c might be inevitable, but circumstantial. Alternatively, it may respond to some critical requirements of the redoximbalanced cell, possibly being part of a stress response.
